Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

NCT01797315 is registered in ClinicalTrials.gov with University Hospital of Berlin as lead sponsor.

NCT NCT01797315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01797315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Lead sponsor
University Hospital of Berlin
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2007
Completion date
June 30, 2013
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant patients at high-risk for skin cancer